leadf
logo-loader
viewValley Fever Solutions

Valley Fever Solutions looking forward to beginning Phase II trials to treat Valley Fever

Valley Fever Solutions, Inc. President and CEO David Larwood spoke to Proactive at theBiotech Showcase 2020 in San Francisco. The privately-held, Arizona-based company is developing a potential cure for Valley Fever. According to its website, the company anticipates starting a pivotal trial in Q4 2020.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Water Tower Research President talks Energy and how Capstone Turbine is key...

Water Tower Research Co-Founder and President Shawn Severson joined Steve Darling from Proactive to share some insight about the Energy sector and how it is being viewed by users. Severson also told Proactive about Capstone Turbine and some things investors need to watch for from the company...

1 hour, 42 minutes ago

2 min read